These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10631417)

  • 1. Complement activation by propofol and its effect during propofol anaesthesia.
    Ohmizo H; Iwama H; Sugita T
    Anaesth Intensive Care; 1999 Dec; 27(6):623-7. PubMed ID: 10631417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.
    Pfeifer PH; Kawahara MS; Hugli TE
    Clin Chem; 1999 Aug; 45(8 Pt 1):1190-9. PubMed ID: 10430784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol.
    Ohmizo H; Obara S; Iwama H
    Can J Anaesth; 2005; 52(6):595-9. PubMed ID: 15983144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of FUT-175 (Nafamstat Mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo.
    Issekutz AC; Roland DM; Patrick RA
    Int J Immunopharmacol; 1990; 12(1):1-9. PubMed ID: 2303313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in systemic sclerosis.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    J Clin Lab Immunol; 1990 Jan; 31(1):39-41. PubMed ID: 1966983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study.
    Pfeifer PH; Brems JJ; Brunson M; Hugli TE
    Immunopharmacology; 2000 Feb; 46(2):163-74. PubMed ID: 10647874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage.
    Kasuya H; Shimizu T
    J Neurosurg; 1989 Nov; 71(5 Pt 1):741-6. PubMed ID: 2809729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
    Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
    Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum complement levels and severity of sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma.
    Lee SH; Rhim T; Choi YS; Min JW; Kim SH; Cho SY; Paik YK; Park CS
    Am J Respir Crit Care Med; 2006 Feb; 173(4):370-8. PubMed ID: 16293803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis.
    Abou-Ragheb HH; Williams AJ; Brown CB; Milford-Ward A
    Nephron; 1992; 62(1):22-6. PubMed ID: 1436286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation.
    Aoki H; Mizobe T; Nozuchi S; Hiramatsu N
    Anesthesiology; 1998 Feb; 88(2):362-70. PubMed ID: 9477057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K; Würzner R; Kronenberg F; Oppermann M; König P
    Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of complement by DMSO and ethanol and its inhibition by soluble complement receptor type 1.
    Laver AJ; Hibbs M; Smith RA
    Biochem Soc Trans; 1995 May; 23(2):167S. PubMed ID: 7672193
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement activation during storage of preserved blood].
    Schleunig M; Schmid-Haslbeck M; Wimmer R; Mempel W
    Beitr Infusionsther; 1990; 26():81-5. PubMed ID: 1703907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement activation and interleukin response in major abdominal surgery.
    Kvarnström AL; Sarbinowski RT; Bengtson JP; Jacobsson LM; Bengtsson AL
    Scand J Immunol; 2012 May; 75(5):510-6. PubMed ID: 22229650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.
    Chang TM; Lister C
    Biomater Artif Cells Artif Organs; 1990; 18(5):693-701. PubMed ID: 2099226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.